VTGN - VistaGen Therapeutics Inc. (VTGN) CEO Shawn Singh on Q4 2021 Results - Earnings Call Transcript
VistaGen Therapeutics, Inc. (VTGN) Q4 2021 Earnings Conference Call June 29, 2021 5:00 PM ET Company Participants Mark Flather - Vice President of Investor Relations Shawn Singh - Chief Executive Officer Jerrold Dotson - Vice President, Chief Financial Officer and Secretary Mark Smith - Chief Medical Officer Conference Call Participants Tim Lugo - William Blair Brian Skorney - Robert W. Baird Andrew Tsai - Jefferies Jason McCarthy - Maxim Group Presentation Operator Greetings. Welcome to VistaGen Therapeutics Fiscal Year 2021 Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. A Question-And-Answer Session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to Mark Flather, Vice President of Investor Relations. Thank you. You may begin. Mark Flather Thank you, Sherry. Hello and welcome to the VistaGen Therapeutics 2021 fiscal year end financial
For further details see:
VistaGen Therapeutics, Inc. (VTGN) CEO Shawn Singh on Q4 2021 Results - Earnings Call Transcript